WEST PHARMACEUTICAL SERVICES INC 8-K/A

What Happened
West Pharmaceutical Services, Inc. (WST) filed an 8‑K on May 20, 2026 disclosing a material cybersecurity attack detected on May 4, 2026 and determined to be material on May 7, 2026. The company says an unauthorized party exfiltrated certain data and encrypted some systems. Upon detection the company took systems offline globally, notified law enforcement, and engaged external cyber‑forensic experts. By the filing date core enterprise systems had been restored and manufacturing, receiving and shipping were restarted at all sites; the company reports it is fully operational across manufacturing, supply chain and commercial sites globally.

Key Details

• Incident detected: May 4, 2026; determined material: May 7, 2026; no unauthorized activity observed since May 5, 2026 per the company’s investigation to date.
• Actions taken: global systems taken offline for containment, law enforcement notified, external forensic teams engaged.
• Operational status: core systems restored and critical manufacturing/receiving/shipping processes restarted at all sites; company states it is fully operational.
• Guidance: based on current information, West believes the incident has not had, and is not reasonably likely to have, a material impact on its 2026 second‑quarter or full‑year financial guidance.

Why It Matters
This disclosure is material because it involved data exfiltration and system encryption and required global containment and recovery actions. For investors, the filing signals that operations have been restored and management currently expects no material impact to 2026 guidance, but the investigation is ongoing. Continued monitoring is warranted for any updates on the scope of data affected, potential legal or regulatory consequences, and any revisions to financial guidance.